HHC
REGN icon

Hutchin Hill Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Hutchin Hill Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,700
Closed -$1.33M – 703
2016
Q1 		$1.33M Sell
3,700
-2,300
-38% -$948K 0.05% 367
2015
Q4 		$3.26M Buy
+6,000
New +$3.25M 0.11% 231
2015
Q3 		– Sell
-800
Closed -$408K – 734
2015
Q2 		$408K Buy
+800
New +$390K 0.01% 582
2014
Q3 		– Sell
-7,400
Closed -$2.09M – 699
2014
Q2 		$2.09M Buy
+7,400
New +$2.19M 0.1% 144
2014
Q1 		– Sell
-4,200
Closed -$1.16M – 704
2013
Q4 		$1.16M Sell
4,200
-20,800
-83% -$5.98M 0.08% 255
2013
Q3 		$7.82M Buy
25,000
+2,250
+10% +$592K 0.71% 37
2013
Q2 		$5.12M Buy
+22,750
New +$5.3M 0.53% 38

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return